Analysts think NRXP stock price could increase by 1388%
Aug 02, 2024, 6:25 AM
-13.43%
What does NRXP do
NRX Pharmaceuticals, Inc., a clinical-stage company based in Wilmington, Delaware, specializes in developing treatments for central nervous system disorders such as suicidal depression and PTSD. Key developments include Phase III trials for NRX-101 targeting bipolar depression and initiatives like NRX-100 for anesthesia and ZYESAMI for COVID-19 respiratory failures.
4 analysts think NRXP stock price will increase by 1387.50%. The current median analyst target is $32.13 compared to a current stock price of $2.16. The lowest analysts target is $20.20 and the highest analyst target is $45.15.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
